Washington, D.C. - Congressman Josh Brecheen has shown his unwavering support for Israel by voting in favor of H.R. 7217, a bill that provides emergency supplemental appropriations to respond to the recent attacks in Israel. The legislation aims to address the escalating security concerns faced by Israel due to the actions of terrorist groups across the Middle East.In explaining his vote, Congressman Brecheen emphasized the historical and strategic importance of the United States' alliance with Israel. He stated, "America has played a unique role in Israel's history since...
Washington, D.C. – In a tight vote on the House floor, Congressman Josh Brecheen cast his vote in favor of impeaching Department of Homeland Security Secretary Alejandro Mayorkas. Unfortunately, the motion failed by a slim margin of 216-214 in the House of Representatives.Congressman Brecheen, who serves on the House Homeland Security Committee, made it clear that this was not a decision taken lightly. "I voted for impeachment not because of policy differences or politics, though I disagree with Secretary Mayorkas wholeheartedly," he stated. "The issue at hand is...
Washington, D.C. – Congressman Josh Brecheen has announced a series of in-person town halls in Oklahoma for the month of February. These town halls provide an opportunity for constituents to voice their thoughts and concerns on policy issues impacting Washington, D.C. and Oklahoma.In addition to the in-person events, Congressman Brecheen will be hosting a telephone town hall on Tuesday, February 6th at 7 PM CT. Constituents can participate in the call by dialing 888-480-3675, and a live stream of the call will be available on the Congressman's Facebook page.The schedule...
There was one company in a city associated with Pottawatomie County that received FDA citations as a result of one inspection conducted in the county in January, according to reports from the U.S. Food and Drug Administration (FDA).
There was one company in a city associated with Pottawatomie County that received an FDA inspection in January, according to the U.S. Food and Drug Association.